Literature DB >> 6292474

Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro.

M H Baron, D Baltimore.   

Abstract

A carboxy-terminal peptide of the poliovirus replicase protein (p63) was chemically synthesized, coupled to bovine serum albumin carrier, and injected into rabbits. The resulting antisera reacted with six virus-specific proteins from HeLa cells infected with poliovirus: NCVP 0b, NCVP 1b, NCVP 2, a protein of about 60,000 daltons, p63, and NCVP 6b. The identity of the 60,000-dalton protein is not known, but the other results were consistent with previous experimental approaches which demonstrated that p63 and the other four polypeptides have common coding sequences. An amino-terminal peptide of p63 failed to elicit an immune response in rabbits. Antibodies raised against the p63 carboxy-terminal peptide inhibited poliovirus replicase and polyuridylic acid polymerase activities in vitro, providing strong support for earlier suggestions that these activities are a property of a single virus-specific polypeptide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292474      PMCID: PMC256207     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  The formation of poliovirus proteins.

Authors:  D Baltimore; M F Jacobson; J Asso; A S Huang
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1969

2.  The specificity of antibodies to a peptide determinant of the tobacco mosaic virus protein induced by immunization with the peptide conjugate.

Authors:  F J Fearney; C Y Leung; J D Young; E Benjamini
Journal:  Biochim Biophys Acta       Date:  1971-09-28

3.  Aspects of the synthesis of poliovirus RNA and the formation of virus particles.

Authors:  D Baltimore; M Girard; J E Darnell
Journal:  Virology       Date:  1966-06       Impact factor: 3.616

4.  Immunochemistry of sperm whale myoglobin. I. The specific interaction of some tryptic peptides and of peptides containing all the reactive regions of the antigen.

Authors:  M Z Atassi; B J Saplin
Journal:  Biochemistry       Date:  1968-02       Impact factor: 3.162

5.  Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.

Authors:  R Arnon; E Maron; M Sela; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

6.  Chemical and immunological characterization of a unique antigenic region in lysozyme.

Authors:  E Maron; C Shiozawa; R Arnon; M Sela
Journal:  Biochemistry       Date:  1971-03-02       Impact factor: 3.162

7.  Antibodies to a unique region in lysozyme provoked by a synthetic antigen conjugate.

Authors:  R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1969-01       Impact factor: 11.205

8.  The interpretation of protein structures: estimation of static accessibility.

Authors:  B Lee; F M Richards
Journal:  J Mol Biol       Date:  1971-02-14       Impact factor: 5.469

9.  Comparison of molecular structures of proteins: helix content; distribution of apolar residues.

Authors:  I M Klotz
Journal:  Arch Biochem Biophys       Date:  1970-06       Impact factor: 4.013

10.  Cross-reactions of antisera against the terminal amino acid and dipeptide of tobacco mosaic virus.

Authors:  F A Anderer; H D Schlumberger
Journal:  Biochim Biophys Acta       Date:  1966-01-25
View more
  10 in total

1.  RNA-dependent RNA polymerases of plants.

Authors:  H Fraenkel-Conrat
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase.

Authors:  J M Lubinski; G Kaplan; V R Racaniello; A Dasgupta
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Purification of a soluble template-dependent rhinovirus RNA polymerase and its dependence on a host cell protein for viral RNA synthesis.

Authors:  C D Morrow; J Lubinski; J Hocko; G F Gibbons; A Dasgupta
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Anti-VPg antibody precipitation of product RNA synthesized in vitro by the poliovirus polymerase and host factor is mediated by VPg on the poliovirion RNA template.

Authors:  D C Young; B M Dunn; G J Tobin; J B Flanegan
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Analysis of an evolutionarily conserved antigenic site on mammalian cytochrome c using synthetic peptides.

Authors:  R Jemmerson; P R Morrow; N R Klinman; Y Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

Authors:  H L Niman; R A Houghten; L E Walker; R A Reisfeld; I A Wilson; J M Hogle; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

7.  Poliovirus RNA-dependent RNA polymerase and host cell protein synthesize product RNA twice the size of poliovirion RNA in vitro.

Authors:  D C Young; D M Tuschall; J B Flanegan
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.

Authors:  C D Morrow; J Hocko; M Navab; A Dasgupta
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites.

Authors:  R Harvey; B A Oostra; G J Belsham; P Gillett; A E Smith
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

10.  Homologous sequences in non-structural proteins from cowpea mosaic virus and picornaviruses.

Authors:  H Franssen; J Leunissen; R Goldbach; G Lomonossoff; D Zimmern
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.